• 1
    Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27: 72949.
  • 2
    Healey LA, Wilske KR. Presentation of occult giant cell arteritis. Arthritis Rheum 1980; 23: 6413.
  • 3
    Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981; 24: 14148.
  • 4
    Desmet GD, Knockaert DC, Bobbaers HJ. Temporal arteritis: the silent presentation and delay in diagnosis. J Intern Med 1990; 227: 23740.
  • 5
    Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in the adults in Northwestern Spain, 1988–97: clinical and epidemiological aspects. Medicine (Baltimore) 1999; 78: 292308.
  • 6
    Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Brañas F, Dababneh A, et al. Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000; 79: 28392.
  • 7
    Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WER. The spectrum of polymyalgia rheumatica in Northwestern Spain: incidence and analysis of variables associated with relapse in a ten year study. J Rheumatol 1999; 26: 132632.
  • 8
    Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 67280.
  • 9
    De Kleijn EM, Vandenbroucke JP, van der Meer JW, The Netherlands FUO Study Group. Fever of unknown origin (FUO). I A: prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria.. Medicine (Baltimore) 1997; 76: 392400.
  • 10
    Weyand CM, Hunder NNH, Hicok KC, Hunder GG, Goronzy G: HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994; 37: 51420.
  • 11
    Gonzalez-Gay MA. Genetic epidemiology: giant cell arteritis and polymyalgia rheumatica. Arthritis Res 2001; 3: 1547.
  • 12
    Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy-proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998; 25: 17505.
  • 13
    Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 2001; 60: 36771.
  • 14
    Amoli MM, Shelley E, Mattey DL, Garcia-Porrua C, Thomson W, Hajeer AH, et al. Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica. J Rheumatol 2002; 29: 5024.
  • 15
    Esposito AL, Gleckman RA. Fever of unknown origin in the elderly. J Am Geriatr Soc 1978; 26: 498505.
  • 16
    Strachan RW, How J, Bewsher PD. Masked giant-cell arteritis. Lancet 1980; 1: 1946.
  • 17
    Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998; 41: 2632.
  • 18
    Gonzalez-Gay MA, Garcia-Porrua C, Rodriguez-Ledo P, Llorca J. Trends in the inflammatory response in biopsy-proven giant cell arteritis: comment on the article by Cid et al, and the letters by Nesher and Sonnenblick and Liozon et al. Arthritis Rheum 2000; 43: 14278.
  • 19
    Kaiser M, Younge B, Bjornsson J, Goronzy JJ, Weyand CM. Formation of new vasa vasorum in vasculitis: production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999; 155: 76574.
  • 20
    Cid MC, Hernandez-Rodriguez J, Esteban MJ, Cebrian M, Gho YS, Font C, et al. Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation 2002; 106: 166471.